The Company and its subsidiaries are mainly engaged in the sales of medical equipment. The Company is also involved in the development of drugs, as well as the sales of health care products. The Company has also developed a new oral release film formulation, TAH4411, through its Transepithelia Delivery System (TDS). The Company distributes its products mainly in domestic market. The Company was established in 2010.
Headquarters
3F, No.550, Ruiguang Road
Taipei City; Taipei City;
Contact Details: Purchase the Taho Pharmaceuticals Ltd. (泰合生技药品股份有限公司) report to view the information.
Website: http://www.tahopharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service